Paradigm Biopharmaceuticals Ltd.ASX: PAR

PAR reports successful ross river phase 2 clinical trial

Jun 4, 2019 at 2:52 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment